AI Drug Discovery for Pharma and Biotech

Drug discovery

7

papers

On emerging therapies

Overview

Ring chromosome 18 syndrome is a rare genetic disorder caused by deletions at both ends of chromosome 18, resulting in a ring-shaped chromosome. Clinical features include developmental delay, intellectual disability (ranging from mild to severe), hypotonia, craniofacial abnormalities (microcephaly, hypertelorism, micrognathia), congenital heart defects (e.g., septal defects), skeletal anomalies, and growth retardation [1][3][14][18]. Diagnosis requires karyotyping and molecular confirmation (e.g., FISH or CMA) [1][18].

Population

  • Prevalence: ~1 in 50,000–300,000 live births [2][18].

  • Most cases are de novo; rare familial inheritance (<5%) [5][14].

  • Slightly higher female predominance reported [5][19].

Burden

  • High morbidity: 71% of mortality occurs in infancy due to cardiac/respiratory complications [2][11]. Survivors often require lifelong care for intellectual/developmental disabilities [18].

  • Economic burden: Frequent specialized healthcare utilization (cardiology, neurology, orthopedics) and long-term supportive therapies [8][10].

  • Reduced quality of life: Limited independence in adulthood (minority achieve semi-independent living) [11][18].

Therapies

  • Multidisciplinary care: Early developmental interventions (physical/occupational/speech therapy), cardiac surveillance, and surgical correction for anomalies (cleft palate, cryptorchidism) [3][8][10].

  • Symptomatic management: Growth hormone therapy for deficiency, anticonvulsants for seizures (if present), and immunomodulation for recurrent infections [8][10][18].

  • Genetic counseling and prenatal testing for families with a history of chromosomal abnormalities [5][14].

Categories: rare developmental anomalies during embryogenesis, rare genetic diseases

Research Papers

7 drug discovery papers about Ring chromosome 18 syndrome. Recent publications:

7 drug discovery papers about Ring chromosome 18 syndrome. Recent publications:

categories:

Small molecules

proteins
2025-05-12 | Association of ring chromosome 18 and Prader-Willi syndrome: the first described case report.

Ring chromosome 18 is a rare chromosomal disorder, and its association with Prader-Willi syndrome (PWS) is an extremely unusual condition. We described the clinical and biological profile of this association and highlighted the management of this case through GH therapy. To the best of our knowledge, this is the first reported association in the literature. This report discusses a case of a 9-year-old child diagnosed with both PWS and ring 18 syndrome at the age of 3 years. The diagnosis of Prader-Willi syndrome with ring chromosome 18 was established using CGH ARRAY technique. It showed the absence of expression of paternal chromosome 15 in the 15q11-q13 region, and a karyotype showing ring chromosome 18 according to the formula: 46. XX (37)/46. XX r(18) (p11.3 ;q23) (27). Our case contributes to a better understanding of the clinical presentation of complex aberrations of chromosome 18 and that of PWS. The main common clinical features of this association were a moderate dysmorphic syndrome, hypotonia, grade II obesity with severe OSA, mild cognitive deficit with learning difficulties, and a discreet scoliosis. Diagnosis and management of this complex disorder require a multidisciplinary approach. The primary focus for those patients is to enhance their quality of life and prevent any potential complications.

Open article ↗



1994-05-17 | Hypothalamic growth hormone deficiency in a patient with ring chromosome 18.

We report on a boy with a ring 18 chromosome associated with hypothalamic growth hormone (GH) deficiency. A 12-month trial of GH replacement therapy (0.5 U/kg/week) resulted in a marked growth acceleration. Our findings emphasise the need of evaluating GH secretion in patients with abnormalities of the 18 chromosome.

Open article ↗



1988-09-01 | Growth hormone, suspected gonadotrophin deficiency, and ring 18 chromosome.

A boy with a ring 18 chromosome karyotype was referred because of short stature; he had growth hormone deficiency and possible hypogonadotrophic hypogonadism. Many children with major chromosomal abnormalities are short, but this case emphasises the need to consider growth hormone deficiency in addition.

Open article ↗



proteins
2025-05-12 | Association of ring chromosome 18 and Prader-Willi syndrome: the first described case report.

Ring chromosome 18 is a rare chromosomal disorder, and its association with Prader-Willi syndrome (PWS) is an extremely unusual condition. We described the clinical and biological profile of this association and highlighted the management of this case through GH therapy. To the best of our knowledge, this is the first reported association in the literature. This report discusses a case of a 9-year-old child diagnosed with both PWS and ring 18 syndrome at the age of 3 years. The diagnosis of Prader-Willi syndrome with ring chromosome 18 was established using CGH ARRAY technique. It showed the absence of expression of paternal chromosome 15 in the 15q11-q13 region, and a karyotype showing ring chromosome 18 according to the formula: 46. XX (37)/46. XX r(18) (p11.3 ;q23) (27). Our case contributes to a better understanding of the clinical presentation of complex aberrations of chromosome 18 and that of PWS. The main common clinical features of this association were a moderate dysmorphic syndrome, hypotonia, grade II obesity with severe OSA, mild cognitive deficit with learning difficulties, and a discreet scoliosis. Diagnosis and management of this complex disorder require a multidisciplinary approach. The primary focus for those patients is to enhance their quality of life and prevent any potential complications.

Open article ↗



1994-05-17 | Hypothalamic growth hormone deficiency in a patient with ring chromosome 18.

We report on a boy with a ring 18 chromosome associated with hypothalamic growth hormone (GH) deficiency. A 12-month trial of GH replacement therapy (0.5 U/kg/week) resulted in a marked growth acceleration. Our findings emphasise the need of evaluating GH secretion in patients with abnormalities of the 18 chromosome.

Open article ↗



1988-09-01 | Growth hormone, suspected gonadotrophin deficiency, and ring 18 chromosome.

A boy with a ring 18 chromosome karyotype was referred because of short stature; he had growth hormone deficiency and possible hypogonadotrophic hypogonadism. Many children with major chromosomal abnormalities are short, but this case emphasises the need to consider growth hormone deficiency in addition.

Open article ↗



Access all drug discovery papers and probability of success in trials forecasts:

Access all drug discovery papers and probability of success in trials forecasts:

Drug Discovery Landscape

0 orphan drug designations.

0 orphan drug designations.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.